by University of Oxford Credit: Unsplash/CC0 Public Domain Researchers at the Kennedy Institute, University of Oxford, led by Professor Jagdeep Nanchahal have demonstrated the efficacy of the anti-TNF drug adalimumab for patients with early stage Dupuytren’s disease. Dupuytren’s disease is a common condition of the hand that affects about 5% of the UK population and...
